OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
Xinling Wang, Lujia Sun, Zezhong Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 12
Xinling Wang, Lujia Sun, Zezhong Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 12
Showing 12 citing articles:
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
Lixiao Xing, Zhimin Liu, Xinling Wang, et al.
Cell (2025)
Closed Access | Times Cited: 5
Lixiao Xing, Zhimin Liu, Xinling Wang, et al.
Cell (2025)
Closed Access | Times Cited: 5
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access | Times Cited: 2
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access | Times Cited: 2
STING agonist-based ER-targeting molecules boost antigen cross-presentation
Xiafeng Wang, Zhangping Huang, Lixiao Xing, et al.
Nature (2025)
Open Access | Times Cited: 1
Xiafeng Wang, Zhangping Huang, Lixiao Xing, et al.
Nature (2025)
Open Access | Times Cited: 1
An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms
Wenbo Sun, Tingyu Yang, Fengming Sun, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1809-1819
Closed Access | Times Cited: 5
Wenbo Sun, Tingyu Yang, Fengming Sun, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1809-1819
Closed Access | Times Cited: 5
Development of potent pan‐coronavirus fusion inhibitors with a new design strategy
Yuanmei Zhu, Zhongcai Gao, Xiaoli Feng, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Yuanmei Zhu, Zhongcai Gao, Xiaoli Feng, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk
Shibo Jiang, Fan Wu
Cell (2025) Vol. 188, Iss. 6, pp. 1465-1468
Closed Access
Shibo Jiang, Fan Wu
Cell (2025) Vol. 188, Iss. 6, pp. 1465-1468
Closed Access
Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination
Lujia Sun, Qiuhong Man, Hui Zhang, et al.
Journal of Infection (2024) Vol. 88, Iss. 4, pp. 106138-106138
Open Access | Times Cited: 1
Lujia Sun, Qiuhong Man, Hui Zhang, et al.
Journal of Infection (2024) Vol. 88, Iss. 4, pp. 106138-106138
Open Access | Times Cited: 1
Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins
Daniel Polo-Megías, Mario Cano‐Muñoz, Alberto G. Berruezo, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 130132-130132
Open Access | Times Cited: 1
Daniel Polo-Megías, Mario Cano‐Muñoz, Alberto G. Berruezo, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 130132-130132
Open Access | Times Cited: 1
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie M. Weskamm, Paulina Tarnow, Charlotte Harms, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110470-110470
Open Access | Times Cited: 1
Leonie M. Weskamm, Paulina Tarnow, Charlotte Harms, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110470-110470
Open Access | Times Cited: 1
Receptor-binding domain-associated serotypes of SARS-CoV-2
Zezhong Liu, Lu Lu, Shibo Jiang
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access
Zezhong Liu, Lu Lu, Shibo Jiang
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access
Broad Neutralization Capacity of an Engineered Thermostable Three-Helix Angiotensin-Converting Enzyme 2 Polypeptide Targeting the Receptor-Binding Domain of SARS-CoV-2
Davide Cavazzini, Elisabetta Levati, S. Germani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12319-12319
Open Access
Davide Cavazzini, Elisabetta Levati, S. Germani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12319-12319
Open Access
A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model
Yi Zhang, Jialu Zhang, Dongmei Li, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 484-484
Open Access
Yi Zhang, Jialu Zhang, Dongmei Li, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 484-484
Open Access
